John G McHutchison's Net Worth

$4.27 Million

Estimate Recalculated Nov 8, 2024 09:31PM EST

Who is John G McHutchison

John G McHutchison has an estimated net worth of $4.27 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, ASSEMBLY BIOSCIENCES, INC., and Metacrine, Inc..

SEC CIK

John G McHutchison's CIK is 0001738125

Past Insider Trading and Trends

2019 was John G McHutchison's most active year for acquiring shares with 7 total transactions. John G McHutchison's most active month to acquire stocks was the month of February. 2018 was John G McHutchison's most active year for disposing of shares, totalling 3 transactions. John G McHutchison's most active month to dispose stocks was the month of July. 2018 saw John G McHutchison paying a total of $5,198,686.20 for 87,310 shares, this is the most they've acquired in one year. In 2019 John G McHutchison cashed out on 4,453 shares for a total of $306,143.75, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GILEAD SCIENCES INC

Chief Scientific Off/HeadR&D
Updated Feb 08, 2019
Form 4
327.82%
92.83K
$68.75
-$306.14K
Feb 08, 2019
121.15K
Grant
Feb 06
Form 4
13.27%
3.15K
$65.12
-$194.58K
Dec 19, 2018
26.85K
Grant
Dec 17
Form 4
-2.57%
-664.00
$71.18
-$47.26K
Nov 13, 2018
25.17K
Options
Nov 10
Form 4
79.71K
$65.22
$5.20M
May 10, 2018
79.71K
Grant
May 08
Form 3
Apr 27, 2018
22.91K
Showing 5 results

ASSEMBLY BIOSCIENCES, INC.

Chief Executive Officer
Updated May 30, 2024
Form 4
2.75K
May 30, 2024
2.75K
Grant
May 29
Form 4
-9.98%
-2.12K
$14.93
-$31.61K
May 24, 2024
19.10K
Sale
May 23
Form 4
-5.38%
-1.21K
$13.07
-$15.76K
Apr 02, 2024
21.22K
Sale
Apr 01
Form 4
20.00K
May 30, 2023
20.00K
Grant
May 25
Form 4
24.55%
91.53K
$1.04
-$27.02K
May 24, 2023
464.29K
Grant
May 22 - May 23
Form 4
-7.73%
-14.88K
$0.82
-$12.25K
Mar 31, 2023
177.63K
Sale
Mar 30
Form 4
-6.01%
-12.31K
$2.13
-$26.20K
Aug 10, 2022
192.52K
Sale
ScheduledAug 08
Form 4
396.11%
497.89K
$2.17
-$10.00K
Mar 31, 2022
623.58K
Grant
ScheduledMar 29 - Mar 30
Form 4
-8.82%
-12.16K
$3.60
-$43.78K
Aug 10, 2021
125.69K
Sale
ScheduledAug 09
Form 4
305.00K
Apr 02, 2021
305.00K
Grant
Mar 29
Form 4
-8.10%
-12.15K
$21.80
-$264.92K
Aug 10, 2020
137.85K
Sale
ScheduledAug 07
Form 4
150.00%
150.00K
Mar 31, 2020
250.00K
Grant
Mar 27
Form 4
25.00K
Oct 01, 2019
25.00K
Grant
Sep 28
Form 4
600.00K
Aug 08, 2019
600.00K
Grant
Aug 06
Form 3
Aug 08, 2019
Showing 15 results

Metacrine, Inc.

Investor
Updated Sep 06, 2022
Form 4
16.50K
Sep 06, 2022
16.50K
Grant
May 18
Form 4
16.50K
May 25, 2021
16.50K
Grant
May 24
Form 3
Sep 15, 2020
Showing 3 results